A recent Talcum powder ruling has sent shockwaves through the mass tort litigation community. A judge has allowed for Talcum powder cases to proceed, meaning at least 16,000 plaintiffs are one step closer to reaching a stage where they may receive compensation. This ruling presents a new opening for firms hoping to take on Johnson & Johnson in Talcum powder litigation. Not long after the judge’s ruling, the company decided to discontinue sales of talcum-based powder products in the US and Canada. TSEG wants to help by creating connections between the public and the attorneys they need.
REQUEST A FREE CONSULTATION
TSEG’s team can help you sign more cases
About the Talcum Powder Lawsuit
Talcum powder has been linked to ovarian cancer, but there was no proof of causation. In 2018, a Reuters report found that Johnson & Johnson knew for decades that its Talcum powder products were contaminated with asbestos, a known carcinogen. In April of 2020 a judge awarded plaintiffs major issues in the ongoing litigation of talcum powder. This ruling allows experts to testify on the causation of these illnesses associated with talcum powder. Johnson and Johnson wanted to ban such testimony from talcum powder cases. There are thousands of lawsuits pending against the company, and perhaps more on the way.
Talcum Powder Lawsuit Advertising Opportunities
This is clearly a huge win for the attorneys who have been fighting these cases for years. However, the women who have developed cancer using talcum powder need help now more than ever. They might not be aware that the health issues they face are a result of misconduct by a large corporation. It is important that people affected by Johnson and Johnson’s negligence know who is to blame and understand that they don’t have to take it. TSEG is prepared to help your law firm present itself to potential clients and earn their trust.
Call us at (512) 894-8621 today
to find out more about our lead generation and marketing campaign services or get a free estimate.
How TSEG can Help
TSEG‘s lead generation campaigns put your firm in front of the people who need to hear your message. Our goal for every marketing partner is to hit their case sign-up targets at a fraction of the cost of other marketing companies. We do this by leveraging digital advertising on all major platforms. Our mass tort marketing campaigns ensure your firm reaches the right audience at the right time, maximizing your impact in the Talcum powder litigation and beyond.
J&J Talc Powder Lawsuit Updates 2024
October 2024
A lawsuit involving a Massachusetts real estate developer has ordered Johnson & Johnson, as well as multiple subsidiaries, to pay $15 million in damages to the plaintiff, who maintained that exposure to asbestos resulted in their mesothelioma diagnosis. During the trial, which was carried out in Connecticut, the plaintiff’s lawyers had requested $30 million in damages, while J&J, whose defense suggested that the plaintiff’s illness was due to a genetic mutation and not exposure to asbestos, had offered $4 million.
September 2024
J&J’s new subsidiary, Red River Talc LLC, filed for Chapter 11 in Texas, proposing an $8 billion settlement fund. This move prompted the U.S. Trustee to accuse J&J of “forum shopping” and seek to transfer the case back to New Jersey. Texas bankruptcy judge temporarily halted some talc lawsuits to address jurisdictional questions.
An Oregon state judge overturned a $260 million verdict against J&J, granting a new trial. In the MDL, Judge Shipp rejected consolidation for the first bellwether trial, now set for December with a single plaintiff. A new mesothelioma trial began in Connecticut, highlighting ongoing individual cases.
The MDL grew by 155 cases, totaling 57,937 lawsuits. These developments underscore the complex legal landscape as J&J seeks to resolve its talc liabilities.
August 2024
J&J currently seeks the dismissal of a national class action for medical monitoring. At the same time, it has to deal with a $63 million verdict for asbestos-induced mesothelioma in South Carolina. This significant jury award puts into doubt J&J’s trial plan. On the other hand, preliminary signs point to talcum powder claimants endorsing the most recent settlement plan, suggesting a new phase in the litigation process.
July 2024
The World Health Organization’s recent assessment links Johnson’s Baby Powder to an increased risk of cancer, particularly ovarian cancer. J&J proposed a $6.5 billion settlement to resolve the lawsuits, pending a supermajority agreement from claimants by the end of July. Additionally, J&J’s attempt to discredit plaintiffs’ experts failed, with the court ruling in favor of the expert’s First Amendment protections.
June 2024
The talcum powder litigation continues to evolve with J&J’s $700 million settlement with 43 states over marketing claims. A significant trial is underway in Dallas, Texas, marking the first in the state. The number of pending cases in the MDL increased to 57,365, reflecting a rise in new case volume.
May 2024
New research in the Journal of Clinical Oncology found a strong link between talc use and ovarian cancer, bolstering the plaintiffs’ claims. J&J agreed to a $6.5 billion settlement deal, conditional on plaintiffs’ approval by July 26. This deal covers ovarian cancer claims, while mesothelioma claims are settled separately. The MDL saw a minor increase in new cases, now totaling 53,939.
April 2024
J&J and Kenvue Inc. were ordered to pay $45 million in a mesothelioma case, while a Florida jury ruled in J&J’s favor in an ovarian cancer case. Plaintiffs’ attorneys are contesting the MDL judge’s mandate for a full refiling of Daubert motions. The number of pending cases in the MDL increased by 143, bringing the total to 53,939.
March 2024
A Florida state judge declared a mistrial in a talc powder case after jurors failed to reach a verdict. Plaintiffs’ lawyers are fighting J&J’s attempts to quash subpoenas for documents related to its talc liabilities. The MDL has seen a slowdown in new case filings, with only about 60 new cases added since the start of the year.
February 2024
J&J faced ongoing litigation in multiple states, with new trials beginning in Pennsylvania, Arkansas, and Florida. A state judge allowed old advertisements for J&J baby powder as evidence for punitive damages. The MDL added 34 new cases in January, bringing the total to 53,767. J&J’s efforts to challenge plaintiffs’ experts and attorneys continue, with new subpoenas issued.
January 2024
J&J offered $6.9 billion to settle over 50,000 ovarian cancer claims. The MDL saw a surge in new cases after the bankruptcy stay was lifted, totaling 53,733 pending cases. J&J agreed to a $700 million settlement with over 40 states for deceptive marketing tactics related to talc products. A new class action lawsuit from J&J investors was certified, alleging misleading statements about product safety.
During our initial meeting, we’ll review your budget and any advertising campaigns you’re currently using. We can work on a plan that is cost-effective yet yields successful results.
We know the primary goal of any mass tort campaign is to turn leads into actual clients that sign with your law firm. You can count on the team at TSEG to help you accomplish that. For help with your mass tort campaign
Call us at (512) 394-7234
FREQUENTLY ASKED QUESTIONS
What is a multi-channel approach in mass tort marketing?
A multi-channel approach in mass tort marketing involves deploying campaigns across various platforms such as digital, social media, and traditional media to ensure comprehensive market coverage and maximum engagement. This method leverages different channels to meet potential clients where they are most likely to be receptive to your messaging.
